Regeneron Pharmaceuticals, Inc. (Regeneron) is an integrated biopharmaceutical company, which discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
Fair value: $515
Upward potential: +30%
Average yearly return: 60%
Outperformer
BUY
No comments:
Post a Comment